Literature DB >> 3505918

Survival versus nonsurvival determinants for neonatal harbor seals.

L A Dierauf1, S A Dougherty, L J Lowenstine.   

Abstract

Of 29 neonatal harbor seals that had been abandoned, separated from their mothers, or stranded in the wild, 22 succumbed during hospitalization at the California Marine Mammal Center in the spring of 1982. Compared with standard reported harbor seal pup measurements, 8 of the nonsurviving pups were premature (ie, creamy-white lanugo coat, early pupping season birthdate, and decreased body size [6 to 10 cm shorter and 2.3 to 4.5 kg less than normal]). The premature pups and the young pups (less than or equal to 10 days old) had at least two of the following findings: jaundice, emaciation, labored respiration, hyperbilirubinemia, hypoglobulinemia, or leukopenia. Most of the nonsurviving pups died within 96 hours after admission. Macroscopic and microscopic findings indicated that a high percentage of these pups had pulmonary congestion and edema (72.7%), alveolar squamous cells/debris (27.3%), and/or congenital cardiac anomalies (ie, patent ductus arteriosus [63.6%] and patent foramen ovale [45.4%]). Two older pups (greater than 10 days old) died from chronic bacterial infections, accompanied by adrenal cortical hyperplasia. The 7 surviving pups had adult spotted pelage, normal body weights (9 to 11 kg), normal globulin concentrations (3.0 to 5.1 g/dl), and normal WBC counts (7 to 9 X 10(3)/microliters) and did not have clinical signs of icterus or respiratory distress.

Entities:  

Mesh:

Year:  1986        PMID: 3505918

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  1 in total

1.  Analysis of blood gases, serum fat and serum protein: a new approach to estimate survival chances of stranded Harbor seal (Phoca vitulina) pups from the German North Sea.

Authors:  Katharina A Witte; Jörg Driver; Tanja Rosenberger; Sven Adler; Ursula Siebert
Journal:  Acta Vet Scand       Date:  2014-02-04       Impact factor: 1.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.